A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

A world-first vaccine for the vomiting bug norovirus is being trialled in the UK, with the hope it could cut the "burden" on ...

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

The FDA approves Pfizer's RSV vaccine, Abrysvo, for adults aged 18-59 years with increased risk of the disease.

The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

There are currently no licenced norovirus vaccine anywhere in the world. CEO at the NIHR, Professor Lucy Chappell, added that ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

A randomised clinical trial of an mRNA vaccine against norovirus will be launched in the UK within the next two weeks, it has ...

He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...

The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks, with results so far showing ...